Guangdong Hybribio Biotech Co.,Ltd.’s Net Profit Dropped 91.6% in First Quarter of 2023

Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) (300639.SZ) reported a net profit of 46.3 million yuan in the first quarter of 2023, down 91.6% year-on-year.

Meanwhile, the company posted 302.1 million yuan in revenue, down 80% year-on-year.

At the end of the reporting period, it had 6.4 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 18.6%.